Optimal antiplatelet therapy after revascularization of left subclavian artery during TEVAR
M Shi, H Fang, Y Wu, H Li, C Sheng, S Li… - Journal of Cardiothoracic …, 2024 - Springer
Background Thoracic endovascular aortic repair (TEVAR) is a minimally invasive technique
used to treat type B aortic dissections. Left subclavian artery (LSA) reconstruction is required …
used to treat type B aortic dissections. Left subclavian artery (LSA) reconstruction is required …
Innovative approaches to risk stratification in interventional cardiology
F Crea - European Heart Journal, 2024 - academic.oup.com
This Focus Issue on interventional cardiology and cardiac and vascular surgery contains a
State of the Art Review article entitled 'Aspirinfree antiplatelet strategies after percutaneous …
State of the Art Review article entitled 'Aspirinfree antiplatelet strategies after percutaneous …
Monotherapy with P2Y12-inhibitors after dual antiplatelet therapy: Filling gaps in evidence
G Andò, L Lombardo, G Alagna, A Micari… - International Journal of …, 2024 - Elsevier
Abstract Background Whether P2Y 12 inhibitor monotherapy (P2Y 12-I) is superior to aspirin
following DAPT discontinuation post-PCI remains to be established. Methods We updated …
following DAPT discontinuation post-PCI remains to be established. Methods We updated …